In vitro complement activation favoring soluble C5b-9 complex formation alters myocellular sodium homeostasis

W Wang1, K Okamoto, J Rounds

  • 1Laboratory for Surgical Metabolism and Nutrition, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Surgery
|February 15, 2001
PubMed

Insights

Soluble C5b-9 complexes (SC5b-9) disrupt sodium (Na+) balance in skeletal muscle during sepsis. These effects involve G-proteins, calcium (Ca2+) flux, and Na+,K+-ATPase inhibition.

Area of Science:

  • Complement System Biology
  • Sepsis Pathophysiology
  • Skeletal Muscle Physiology

Background:

  • Sepsis-induced complement activation dysregulates skeletal muscle Na+ homeostasis.
  • Soluble C5b-9 complexes (SC5b-9), previously considered inert, may exert significant biological effects.
  • Investigating SC5b-9's role in myocellular ion balance is crucial for understanding sepsis complications.

Purpose of the Study:

  • To determine the impact of SC5b-9 on myocellular ion homeostasis in skeletal muscle.
  • To elucidate the underlying mechanisms by which SC5b-9 affects ion balance.

Main Methods:

  • Isolated rat extensor digitorum longus (EDL) muscles were incubated with zymosan-activated rat serum (source of SC5b-9) or control serum.
  • Experiments involved pertussis toxin, Ca2+-free buffer, thapsigargin (Ca2+ depletion), and ouabain (Na+,K+-ATPase inhibition).
  • Intracellular Na+ and K+ ([Na+]i, [K+]i) were quantified using flame photometry.

Main Results:

  • Zymosan-activated rat serum significantly increased [Na+]i in EDL muscle, with no change in [K+]i.
  • These SC5b-9-mediated effects were abolished by pertussis toxin, Ca2+ removal, or thapsigargin.
  • Ouabain increased [Na+]i and decreased [K+]i similarly in both activated and control serum groups, indicating Na+,K+-ATPase involvement.

Conclusions:

  • Zymosan-activated rat serum (SC5b-9 enriched) selectively disrupts Na+ homeostasis in fast-twitch skeletal muscle.
  • Mechanisms involve G-proteins, Ca2+ flux, and blockade of the Na+,K+-adenosine triphosphatase pump.
  • SC5b-9 represents a novel therapeutic target for sepsis-related muscle dysfunction.
Abstract